Advanced Micro Devices
AMD
ASML Holding
ASML
Meta Platforms
META
Cisco
CSCO
Taiwan Semiconductor
TSM
US Stock MarketDetailed Quotes
FHTX Foghorn Therapeutics
- 4.820
- -0.270-5.30%
Close Dec 27 16:00 ET
- 4.820
- 0.0000.00%
Post 16:01 ET
267.96MMarket Cap-2.61P/E (TTM)
5.220High4.650Low204.49KVolume5.090Open5.090Pre Close990.64KTurnover0.79%Turnover RatioLossP/E (Static)55.59MShares10.25052wk High-9.47P/B125.58MFloat Cap2.70052wk Low--Dividend TTM26.05MShs Float28.265Historical High--Div YieldTTM11.20%Amplitude2.700Historical Low4.844Avg Price1Lot Size
About Foghorn Therapeutics Company
Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology. Through its scalable Gene Traffic Control product platform, the firm is systematically interrogating and drugging the chromatin regulatory system. The company was founded by Cigall Kadoch, Gerald W. Crabtree and Douglas G. Cole in October 2015 and is headquartered in Cambridge, MA.
Company Profile
SymbolFHTX
Company NameFoghorn Therapeutics
Listing DateOct 23, 2020
Issue Price16.00
Founded2015
CEOMr. Adrian Gottschalk
MarketNASDAQ
Employees116
Fiscal Year Ends12-31
Address500 Technology Square,Suite 700
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-617-586-3100
Websitehttp://www.foghorntx.com
Company Executives
- Name
- Position
- Salary
- Adrian Gottschalk
- Chief Executive Officer and Director
- 2.50M
- Dr. Alfonso Quintas-Cardama
- Chief Medical Officer
- 1.84M
- Kristian F. Humer
- Chief Financial Officer and Principal Accounting Officer
- --
- Michael J. LaCascia
- Chief Legal Officer
- --
- Carlos Costa
- Chief People Officer
- --
- Fanny Cavalie
- Chief Strategy and Business Operations Officer
- --
- Dr. Steven F. Bellon, PhD
- Chief Scientific Officer
- 1.19M
- Dr. Douglas G. Cole, M.D.
- Chairman of the Board
- 184.57K
- B. Lynne Parshall, Esq.,J.D.
- Independent Director
- 157.65K
- Dr. Thomas J. Lynch
- Independent Director
- 145.57K
- Dr. Adam M. Koppel, M.D.,PhD
- Independent Director
- 153.07K
- Ian F. Smith
- Independent Director
- 141.57K
- Dr. Scott Biller, PhD
- Independent Director
- 145.57K
- Dr. Balkrishan Gill, PhD
- Independent Director
- 159.07K
- Dr. Michael Mendelsohn, M.D.
- Independent Director
- 154.57K
- Stephen J. DiPalma
- Treasurer
- --
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.